Riverhead Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $357K | Buy |
8,016
+3,300
| +70% | +$147K | 0.01% | 875 |
|
|
2019
Q2 | $195K | Buy |
4,716
+778
| +20% | +$32.2K | 0.01% | 1157 |
|
|
2019
Q1 | $159K | Buy |
3,938
+1,040
| +36% | +$42K | 0.01% | 1213 |
|
|
2018
Q4 | $110K | Sell |
2,898
-6,602
| -69% | -$251K | ﹤0.01% | 1277 |
|
|
2018
Q3 | $376K | Hold |
9,500
| – | – | 0.01% | 898 |
|
|
2018
Q2 | $334K | Hold |
9,500
| – | – | 0.01% | 849 |
|
|
2018
Q1 | $332K | Hold |
9,500
| – | – | 0.01% | 835 |
|
|
2017
Q4 | $330K | Hold |
9,500
| – | – | 0.01% | 848 |
|
|
2017
Q3 | $322K | Hold |
9,500
| – | – | 0.02% | 775 |
|
|
2017
Q2 | $324K | Hold |
9,500
| – | – | 0.02% | 746 |
|
|
2017
Q1 | $296K | Hold |
9,500
| – | – | 0.02% | 674 |
|
|
2016
Q4 | $260K | Hold |
9,500
| – | – | 0.02% | 660 |
|
|
2016
Q3 | $312K | Sell |
9,500
-11,356
| -54% | -$373K | 0.02% | 582 |
|
|
2016
Q2 | $630K | Sell |
20,856
-40,290
| -66% | -$1.22M | 0.02% | 554 |
|
|
2016
Q1 | $1.72M | Sell |
61,146
-2,054
| -3% | -$57.8K | 0.02% | 559 |
|
|
2015
Q4 | $2.15M | Hold |
63,200
| – | – | 0.03% | 506 |
|
|
2015
Q3 | $2.01M | Hold |
63,200
| – | – | 0.03% | 476 |
|
|
2015
Q2 | $2.01M | Hold |
63,200
| – | – | 0.03% | 475 |
|
|
2015
Q1 | $2.16M | Hold |
63,200
| – | – | 0.03% | 470 |
|
|
2014
Q4 | $2.22M | Hold |
63,200
| – | – | 0.03% | 461 |
|
|
2014
Q3 | $2.26M | Hold |
63,200
| – | – | 0.04% | 440 |
|
|
2014
Q2 | $2.35M | Hold |
63,200
| – | – | 0.04% | 411 |
|
|
2014
Q1 | $2.05M | Buy |
+63,200
| New | +$2.05M | 0.04% | 397 |
|
|
2013
Q3 | – | Sell |
-84,000
| Closed | -$1.99M | – | 426 |
|
|
2013
Q2 | $1.99M | Buy |
+84,000
| New | +$1.99M | 0.07% | 278 |
|